Literature DB >> 22370148

Predictors of quality of life in inpatients with schizophrenia.

Koichiro Fujimaki1, Shigeru Morinobu, Hidehisa Yamashita, Terumichi Takahashi, Shigeto Yamawaki.   

Abstract

Shortening hospital stays has become a key focus in psychiatric care in recent years. However, patients with schizophrenia account for about 60% of inpatients in psychiatry departments in Japan. This study was designed to investigate the relationship between quality of life (QOL) and key indicators for long-term hospital stays among schizophrenia inpatients. A further aim was to elucidate the clinical determinants of QOL among long-stay inpatients. The study sample consisted of 217 inpatients with schizophrenia. Age, duration of illness, duration of hospitalization, years of education, body mass index, neurocognitive function, drug-induced extrapyramidal symptoms, involuntary movements, psychiatric symptoms, and dose equivalents of antipsychotics and anticholinergic agents were used as index factors. Pearson linear correlation and regression analyses were performed to examine the associations between QOL and the above-mentioned factors. Negative symptoms, psychological discomfort, and resistance as rated on the Brief Psychiatric Rating Scale (BPRS) were correlated with all subscale scores of the Japanese version of the Schizophrenia Quality of Life Scale (JSQLS). Stepwise regression showed that negative symptoms, psychological discomfort, and resistance predicted the dysfunction of psycho-social activity score and the dysfunction of motivation and energy score on the JSQLS. This study shows that active treatment for negative symptoms, psychological discomfort, and resistance should be recommended to improve QOL among inpatients with schizophrenia.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370148     DOI: 10.1016/j.psychres.2011.10.023

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

Review 1.  Tardive Dyskinesia Associated with Atypical Antipsychotics: Prevalence, Mechanisms and Management Strategies.

Authors:  Katharina Stegmayer; Sebastian Walther; Peter van Harten
Journal:  CNS Drugs       Date:  2018-02       Impact factor: 5.749

Review 2.  The genetics of drug-related movement disorders, an umbrella review of meta-analyses.

Authors:  Nadine C van der Burg; Asmar F Y Al Hadithy; Peter N van Harten; Jim van Os; P Roberto Bakker
Journal:  Mol Psychiatry       Date:  2020-02-04       Impact factor: 15.992

3.  Subjective Well-Being Under Neuroleptics Scale short form (SWN-K): reliability and validity in an Estonian speaking sample.

Authors:  Liina Haring; René Mõttus; Peeter Jaanson; Raine Pilli; Kairi Mägi; Eduard Maron
Journal:  Ann Gen Psychiatry       Date:  2013-09-11       Impact factor: 3.455

Review 4.  Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options.

Authors:  Pierre Chue; Justine K Lalonde
Journal:  Neuropsychiatr Dis Treat       Date:  2014-05-08       Impact factor: 2.570

5.  The assessment of quality of life in clinical practice in patients with schizophrenia.

Authors:  Anne Karow; Linus Wittmann; Daniel Schöttle; Ingo Schäfer; Martin Lambert
Journal:  Dialogues Clin Neurosci       Date:  2014-06       Impact factor: 5.986

6.  Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.

Authors:  Breno F Cruz; Camilo B de Resende; Carolina F Carvalhaes; Clareci S Cardoso; Antonio L Teixeira; Richard S Keefe; Fábio L Rocha; João V Salgado
Journal:  Braz J Psychiatry       Date:  2016-06-14       Impact factor: 2.697

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.